Uterine Disorders Flashcards
Endometrial cancer incidence
Incidence 33 in 100,000
Peak incidence between 65 and 75
Endometrial cancer pathophysiology
Most commonly adenocarcinoma – due to stimulation of endometrium by oestrogen without protective effects of progesterone
Endometrial hyperplasia can predispose to atypia, a precancerous state
Endometrial cancer risk factors
- Anovulation – early menarche/later menopause, low parity, PCOS, HRT, tamoxifen
- Increasing age
- Obesity – faster rate of peripheral aromatisation of androgens to oestrogen
- Heredity factors – lynch syndrome
Endometrial cancer presentation
Main clinical feature is postmenopausal bleeding
- 75-90% of women with endometrial cancer present with PMB
- 90% of women with PMB do have endometrial cancer
- Younger women may present with irregular or intermenstrual bleeding
Endometrial cancer investigations
1st line investigation is a TV USS – endometrial thickness > 5mm
- If thickness of > 4mm in postmenopausal women -> endometrial biopsy
- Can be performed in outpatients with a pipelle biopsy
- If high risk then hysteroscopy with biopsy performed – outpatient or under GA
- If malignancy confirmed then MRI/CT may be used for staging
Endometrial cancer staging
Stage 1 – confined within uterine body
- A – endometrium
- B – myometrium
Stage 2 – into cervix but not beyond uterus
Stage 3 – carcinoma extends beyond uterus but in confined to pelvis
- Ovaries, vagina, lymph nodes
Stage 4 – Involves bladder or bowel or metastasized to distant sites
Endometrial cancer management
Stage 1 – total hysterectomy and bilateral salpingo-oophorectomy
- Peritoneal washings also taken
- 75% women present with stage 1 and 5 year survival rate of 90%
Stage 2 – radical hysterectomy – vaginal tissues surrounding cervix and supporting ligaments removed
- May be offered adjuvant radiotherapy
Stage 3/4 – maximal de-bulking surgery
- Additional chemotherapy and radiotherapy
- Palliative approach may be preferred – low dose radiotherapy or high dose oral progestogens
Define adenomyosis
Presence of functional endometrial tissue within the myometrium of the uterus
Pathophysiology of adenomyosis
Endometrial stroma allowed to communicate with underlying myometrium after uterine damage
Oestrogen, progesterone and androgen receptors found in ectopic endometrial tissue making it responsive to hormones
Invasion can be focal or diffuse - commonly found in posterior wall
Adenomyoma - collection of endometrial glands form grossly visible nodule
Risk factors for adenomyosis
Pregnancy and childbirth
High parity
Caesarean section
Uterine surgery - endometrial curettage, endometrial ablation
Surgical management of miscarriage or TOP
Hereditary occurrence
Clinical features of adenomyosis
Menorrhagia
Dysmenorrhoea - begins as cyclical pain but can worsen to daily pain
Deep dyspareunia
Irregular bleeding
Differential diagnosis of adenomyosis
Endometriosis
Fibroids
Endometrial hyperplasia/endometrial carcinoma
Endometrial polyps - not commonly associated with dysmenorrhoea
Pelvic Inflammatory Disease - pelvic pain rather than cyclical pain/dysmenorrhoea
Hypothyroidism and coagulation disorders - menorrhagia
Investigations for adenomyosis
Definitive diagnosis is histological after hysterectomy
Imaging
- TV USS - globular uterine configuration, poor definition of endometrial-myometrial interface, myometrial AP asymmetry, intramyometrial cysts and heterogeneous myometrial echo texture
- MRI - endo-myometrial junctional zone, irregular thickening
Management of adenomyosis
Symptom control
- hormone therapy - reduced proliferation of ectopic endometrial cells
- COCP
- progestogens - oral or intrauterine system
- gonadotropin-releasing hormone agonists
- aromatase inhibitors
- non hormonal
- hysterectomy - only definitive treatment
- uterine artery embolisation - block blood supply to adenomyosis causing it to shrink
Define endometriosis
Endometrial tissue located in other sites than the uterine cavity